Bionor Pharma is a leading vaccine company, searching for breakthrough treatments for HIV and other deadly viruses.

Modified Peptide based vaccinesen/Vaccines_+_technology/Platform_technology/The key to kill virusen/Vaccines_+_technology/Platform_technology/Vacc-4x kills virus producing cells.en/Vaccines_+_technology/HIV_vaccine_Vacc-4x/

Latest news

Hide mandatory notifications of trade

Bionor appoints new Chairman and three Non-Executive Directors

Financial .2015

(Oslo, Norway, 13 May 2015) Bionor Pharma ASA (OSE:BIONOR), a peptide vaccine company advancing the potential first therapeutic vaccine towards a functional cure for HIV announces, following today’s Annual General Meeting, the appointment of a new Chairman and three Non-Executive Directors.

Bionor Pharma: Annual General Meeting Approves All Items

Financial .2015

(Oslo, 13 May 2015) The Annual General Meeting of Bionor Pharma ASA today adopted all the items as proposed on the agenda.

Bionor Pharma - First Quarter 2015 results

Financial .2015

(Oslo, 13.05.2015) Bionor Pharma ASA (OSE: BIONOR) announced today its financial results for the first quarter 2015 and update on its clinical development program.

Bionor appoints new Chairman and three Non-Executive Directors

Financial .2015

(Oslo, Norway, 13 May 2015) Bionor Pharma ASA (OSE:BIONOR), a peptide vaccine company advancing the potential first therapeutic vaccine towards a functional cure for HIV announces, following today’s Annual General Meeting, the appointment of a new Chairman and three Non-Executive Directors.

Bionor Pharma: Annual General Meeting Approves All Items

Financial .2015

(Oslo, 13 May 2015) The Annual General Meeting of Bionor Pharma ASA today adopted all the items as proposed on the agenda.

Bionor Pharma - First Quarter 2015 results

Financial .2015

(Oslo, 13.05.2015) Bionor Pharma ASA (OSE: BIONOR) announced today its financial results for the first quarter 2015 and update on its clinical development program.

Go to news section

Featured content